RSV and influenza activity remain at low levels in the EU/EEA; however, circulation of both viruses has begun to increase, with rises in the number

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 1-7 November 2025, and includes updates on respiratory virus epidemiology in the

In this episode of ECDC On Air, we discuss the seasonal spread of respiratory viruses with ECDC’s Principal Expert in Respiratory Viruses – Angeliki Melidou.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 25 October – 1 November 2025, and includes updates on respiratory virus

RSV and influenza transmission remain low in the EU/EEA; however, circulation for both viruses has begun to increase in some countries. COVID-19 circulation, while still

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 18-24 October 2025, and includes updates on respiratory viruses, monkeypox virus clade

In this episode of ECDC On Air, we discuss the seasonal spread of respiratory viruses with ECDC’s Principal Expert in Respiratory Viruses – Angeliki Melidou.

Infographic on the risks posed by respiratory viruses and how to protect your community from infection.

Infographic on protecting yourself and the most vulnerable against respiratory viruses.

As Europe enters the autumn and winter months, respiratory infections are expected to considerably affect the health of individuals vulnerable to severe outcomes. Young children,

We estimated XBB.1.5 vaccine effectiveness (VE) against symptomatic SARS-CoV-2 infection among adults aged ≥ 65 years during the 2023/2024 JN.1 lineage-predominant period in a European

During the first year of the COVID-19 pandemic, vaccination programmes targeted children and adolescents to prevent severe outcomes of SARS-CoV-2 infection.AimTo estimate COVID-19 vaccine effectiveness